SEC Form 4/A · accession 0001144204-18-020331
Cyclacel Pharmaceuticals, Inc. · CYCC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Judy Chiao
Officer — V.P., Clin. Dev. & Reg. Aff.
Period of report
Jan 25, 2013
Accepted (ET)
Apr 12, 2018 · 5:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001130166
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value per shareF1 | Jan 25, 2013 | A | 5,668 | $0.00 | A | 44,692 | D | |
| Common Stock, $0.001 par value per shareF1 | Jan 25, 2013 | A | 20,000 | $0.00 | A | 39,024 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1An additional 16,428 shares, or 1,369 shares after taking into account the one-for-twelve reverse stock split that took effect in May 2016, were inadvertently added to the reporting person's original Form 4 and to all subsequent Forms 4.